Status:
COMPLETED
Multi-Drug Resistant Bacteria Carriage After Travel
Lead Sponsor:
Hopital Lariboisière
Conditions:
Beta Lactam Resistant Bacterial Infection (Disorder)
Eligibility:
All Genders
18+ years
Brief Summary
During one month, from 1st to 30th November 2016, all patients admitted in one of the medical Dpt of our Hospital (Internal Medicine Dpt, Endocrinology, ICU) will be screened for multi-drug resistant ...
Detailed Description
During one month, from 1st to 30th November 2016, all patients admitted in one of the medical Dpt of our Hospital (Internal Medicine Dpt, Endocrinology, ICU) will be screened for multi-drug resistant ...
Eligibility Criteria
Inclusion
- All patients admitted in one of the medical Dpt of our Hospital who have travelled in a foreign country during the previous year
Exclusion
- patients who were unable to give written consent
Key Trial Info
Start Date :
November 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03477760
Start Date
November 1 2016
End Date
December 1 2016
Last Update
March 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
URT, Hopital Lariboisiere
Paris, Île-de-France Region, France, 75475